Which closed-end funds own Cogent Biosciences Inc?
5 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $27.9M. Security type: common equity. Country: United States. CUSIP 19240Q201 · ISIN US19240Q2012 · ticker COGT.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 0.79% | $8.6M | 221,514 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 0.76% | $10.4M | 267,937 sh | $1.4B | 7.5% discount | Jun 30, 2026 |
| HQL abrdn Life Sciences Investors | Healthcare | 0.70% | $4.8M | 125,297 sh | $690M | 3.5% discount | Jun 30, 2026 |
| BME BlackRock Health Sciences Trust | Healthcare | 0.70% | $4M | 103,620 sh | $573M | 3.7% discount | Jun 30, 2026 |
| GRX Gabelli Healthcare & WellnessRx Trust | Healthcare | 0.06% | $135K | 3,500 sh | $228M | NAV unavailable | Jun 30, 2026 |
5 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: COGENT BIOSCIENCES INC.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Cogent Biosciences Inc | debt security | 7 |
Issuer-level search for “COGT” → · Compare two funds’ portfolios →